• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N6- 糠基腺嘌呤通过信号转导亨廷顿蛋白磷酸化对亨廷顿病模型具有保护作用。

N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylation.

机构信息

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.

Department of Pharmacology, University of Alberta, Edmonton, AB T6G 2R3, Canada.

出版信息

Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7081-E7090. doi: 10.1073/pnas.1801772115. Epub 2018 Jul 9.

DOI:10.1073/pnas.1801772115
PMID:29987005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6064984/
Abstract

The huntingtin N17 domain is a modulator of mutant huntingtin toxicity and is hypophosphorylated in Huntington's disease (HD). We conducted high-content analysis to find compounds that could restore N17 phosphorylation. One lead compound from this screen was N6-furfuryladenine (N6FFA). N6FFA was protective in HD model neurons, and N6FFA treatment of an HD mouse model corrects HD phenotypes and eliminates cortical mutant huntingtin inclusions. We show that N6FFA restores N17 phosphorylation levels by being salvaged to a triphosphate form by adenine phosphoribosyltransferase (APRT) and used as a phosphate donor by casein kinase 2 (CK2). N6FFA is a naturally occurring product of oxidative DNA damage. Phosphorylated huntingtin functionally redistributes and colocalizes with CK2, APRT, and N6FFA DNA adducts at sites of induced DNA damage. We present a model in which this natural product compound is salvaged to provide a triphosphate substrate to signal huntingtin phosphorylation via CK2 during low-ATP stress under conditions of DNA damage, with protective effects in HD model systems.

摘要

亨廷顿病(HD)中,突变型亨廷顿蛋白毒性的调节剂——亨廷顿 N17 结构域发生低磷酸化。我们通过高通量分析寻找能够恢复 N17 磷酸化的化合物,筛选出的一种先导化合物为 N6-糠基腺嘌呤(N6FFA)。N6FFA 可保护 HD 模型神经元,且 N6FFA 可纠正 HD 小鼠模型的表型,消除皮质突变型亨廷顿蛋白包涵体。我们发现,N6FFA 可通过腺嘌呤磷酸核糖基转移酶(APRT)被回收为三磷酸形式,再由酪蛋白激酶 2(CK2)作为磷酸供体,从而恢复 N17 磷酸化水平。N6FFA 是氧化 DNA 损伤的天然产物。磷酸化的亨廷顿蛋白在诱导的 DNA 损伤部位,通过功能性重分布与 CK2、APRT 和 N6FFA DNA 加合物共定位。我们提出了一个模型,即在 DNA 损伤条件下低 ATP 应激时,该天然产物化合物通过 CK2 被回收为三磷酸底物,从而为信号转导提供磷酸化底物,对 HD 模型系统具有保护作用。

相似文献

1
N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylation.N6- 糠基腺嘌呤通过信号转导亨廷顿蛋白磷酸化对亨廷顿病模型具有保护作用。
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7081-E7090. doi: 10.1073/pnas.1801772115. Epub 2018 Jul 9.
2
DNA Repair Signaling of Huntingtin: The Next Link Between Late-Onset Neurodegenerative Disease and Oxidative DNA Damage.亨廷顿蛋白的 DNA 修复信号:迟发性神经退行性疾病与氧化 DNA 损伤之间的下一个联系。
DNA Cell Biol. 2019 Jan;38(1):1-6. doi: 10.1089/dna.2018.4476. Epub 2018 Nov 27.
3
Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization.亨廷顿蛋白N17结构域是一种调节亨廷顿蛋白磷酸化和定位的活性氧传感器。
Hum Mol Genet. 2016 Sep 15;25(18):3937-3945. doi: 10.1093/hmg/ddw234. Epub 2016 Jul 27.
4
Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.突变型亨廷顿蛋白和糖原合成酶激酶 3-β在亨廷顿病的一种前症状敲入小鼠模型的神经元脂筏中积累。
J Neurosci Res. 2010 Jan;88(1):179-90. doi: 10.1002/jnr.22184.
5
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.亨廷顿舞蹈病遗传模型中腺苷A1受体的表达、药理学及功能活性
Neurobiol Dis. 2014 Nov;71:193-204. doi: 10.1016/j.nbd.2014.08.013. Epub 2014 Aug 15.
6
Kinase inhibitors modulate huntingtin cell localization and toxicity.激酶抑制剂调节亨廷顿蛋白细胞定位和毒性。
Nat Chem Biol. 2011 May 29;7(7):453-60. doi: 10.1038/nchembio.582.
7
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.亨廷顿病患者大脑中糖原合酶激酶-3和坍塌反应调节蛋白-2的局部变化。
Hum Mol Genet. 2014 Aug 1;23(15):4051-63. doi: 10.1093/hmg/ddu119. Epub 2014 Mar 14.
8
The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.mGluR5 正变构调节剂 CDPPB 改善亨廷顿病小鼠模型的病理和表型特征。
Neurobiol Dis. 2015 Jan;73:163-73. doi: 10.1016/j.nbd.2014.08.021. Epub 2014 Aug 24.
9
Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions.活细胞成像和生物光子学方法揭示了两种类型的突变亨廷顿蛋白包涵体。
Hum Mol Genet. 2014 May 1;23(9):2324-38. doi: 10.1093/hmg/ddt625. Epub 2013 Dec 11.
10
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.半胱胺可提高亨廷顿舞蹈病转基因小鼠大脑以及聚谷氨酰胺聚集的PC12模型中的L-半胱氨酸水平。
J Neurochem. 2004 Oct;91(2):413-22. doi: 10.1111/j.1471-4159.2004.02726.x.

引用本文的文献

1
Untargeted Metabolomics and Targeted Phytohormone Profiling of Sweet Aloes () from Guyana: An Assessment of Asthma Therapy Potential in Leaf Extracts and Latex.圭亚那甜芦荟的非靶向代谢组学和靶向植物激素分析:对叶提取物和乳胶中哮喘治疗潜力的评估
Metabolites. 2025 Mar 5;15(3):177. doi: 10.3390/metabo15030177.
2
The N17 domain of huntingtin as a multifaceted player in Huntington's disease.亨廷顿蛋白的N17结构域在亨廷顿病中扮演多面角色。
Front Mol Biosci. 2025 Jan 7;11:1527313. doi: 10.3389/fmolb.2024.1527313. eCollection 2024.
3
Protein modification in neurodegenerative diseases.神经退行性疾病中的蛋白质修饰
MedComm (2020). 2024 Aug 4;5(8):e674. doi: 10.1002/mco2.674. eCollection 2024 Aug.
4
Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases.异常的蛋白质翻译后修饰会诱导蛋白质聚集和异常沉积,介导神经退行性疾病。
Cell Biosci. 2024 Feb 12;14(1):22. doi: 10.1186/s13578-023-01189-y.
5
IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathway.IKBKB 通过非经典 IKK 途径磷酸化丝氨酸 13 减少亨廷顿蛋白聚集。
Life Sci Alliance. 2023 Aug 8;6(10). doi: 10.26508/lsa.202302006. Print 2023 Oct.
6
Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases.氧化还原失调作为 DNA 损伤的驱动因素及其与神经退行性疾病的关系。
Transl Neurodegener. 2023 Apr 14;12(1):18. doi: 10.1186/s40035-023-00350-4.
7
Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease.蛋白激酶CK2及其作为亨廷顿舞蹈病治疗靶点的潜在作用。
Biomedicines. 2022 Aug 15;10(8):1979. doi: 10.3390/biomedicines10081979.
8
Recent Microscopy Advances and the Applications to Huntington's Disease Research.近期显微镜技术的进展及其在亨廷顿病研究中的应用。
J Huntingtons Dis. 2022;11(3):269-280. doi: 10.3233/JHD-220536.
9
Discovery of Therapeutics Targeting Oxidative Stress in Autosomal Recessive Cerebellar Ataxia: A Systematic Review.常染色体隐性遗传性小脑共济失调中靶向氧化应激的治疗方法的发现:一项系统评价
Pharmaceuticals (Basel). 2022 Jun 19;15(6):764. doi: 10.3390/ph15060764.
10
CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease.CK2 alpha prime 和 alpha-synuclein 的致病功能相互作用介导亨廷顿病中的突触失调。
Acta Neuropathol Commun. 2022 Jun 3;10(1):83. doi: 10.1186/s40478-022-01379-8.

本文引用的文献

1
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity.增强线粒体蛋白质稳态可减少淀粉样β蛋白毒性。
Nature. 2017 Dec 14;552(7684):187-193. doi: 10.1038/nature25143. Epub 2017 Dec 6.
2
Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.蛋白水解结构域内的翻译后修饰聚类可降低突变型亨廷顿蛋白的毒性。
J Biol Chem. 2017 Nov 24;292(47):19238-19249. doi: 10.1074/jbc.M117.782300. Epub 2017 Sep 27.
3
Neuroprotective Effects of Kinetin Against Glutamate-Induced Oxidative Cytotoxicity in HT22 Cells: Involvement of Nrf2 and Heme Oxygenase-1.激动素对 HT22 细胞谷氨酸诱导的氧化细胞毒性的神经保护作用:涉及 Nrf2 和血红素加氧酶-1。
Neurotox Res. 2018 May;33(4):725-737. doi: 10.1007/s12640-017-9811-0. Epub 2017 Sep 12.
4
Evaluation of the Potency of Kinetin on Radiation Induced Behavioural Changes in Swiss Albino Mice.激动素对瑞士白化小鼠辐射诱导行为变化的效力评估
J Clin Diagn Res. 2017 Jul;11(7):TF01-TF04. doi: 10.7860/JCDR/2017/25171.10226. Epub 2017 Jul 1.
5
Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.激动素对氯化铝和 D-半乳糖诱导的小鼠认知障碍和氧化损伤的保护作用。
Brain Res Bull. 2017 Sep;134:262-272. doi: 10.1016/j.brainresbull.2017.08.014. Epub 2017 Sep 1.
6
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.鉴定与亨廷顿病进展相关的遗传变异:全基因组关联研究。
Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.
7
Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks.蛋白激酶CK2:调节细胞网络中的复杂关系
Pharmaceuticals (Basel). 2017 Mar 5;10(1):27. doi: 10.3390/ph10010027.
8
Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex.亨廷顿蛋白是ATM氧化DNA损伤反应复合物中的一种支架蛋白。
Hum Mol Genet. 2017 Jan 15;26(2):395-406. doi: 10.1093/hmg/ddw395.
9
The Plant Hormone Cytokinin Confers Protection against Oxidative Stress in Mammalian Cells.植物激素细胞分裂素赋予哺乳动物细胞抗氧化应激保护作用。
PLoS One. 2016 Dec 22;11(12):e0168386. doi: 10.1371/journal.pone.0168386. eCollection 2016.
10
Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.氧化应激与亨廷顿舞蹈症:益处、危害与严峻之处
J Huntingtons Dis. 2016 Oct 1;5(3):217-237. doi: 10.3233/JHD-160205.